Today’s price, $167, sits below the range. 37.9% below the $268.03 the four methods put it at.
UNDERVALUEDThe real sections, opened with your free account.
The 3 methods put Gilead Sciences’s fair value around $268 a share.
Latest report: July to September 2026 (quarter ended Sep 30, 2026), reported Oct 29, 2026 after the close.
From the company's quarterly statements through Sep 30, 2026.
The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how GILD moved after its last eight reports.
See GILD’s full earnings read, free →